期刊文献+

免疫功能与慢性心力衰竭并发肺部感染的相关性调查 被引量:10

Correlation between immune function and chronic heart failure complicated by pulmonary infections
原文传递
导出
摘要 目的探讨免疫功能与慢性心力衰竭(CHF)并发肺部感染的相关关系,为指导临床治疗提供参考依据。方法选择住院治疗的CHF患者作为研究对象,根据住院期间是否并发肺部感染,分为CHF并发肺部感染组和CHF未并发肺部感染组,比较两组T淋巴细胞亚群(包括CD4+、CD8+和CD4+/CD8+比值)和血清免疫球蛋白(包括IgA、IgG、IgM)的差异,并进行多元回归分析,探讨上述免疫指标对CHF并发肺部感染的影响。结果 CHF并发肺部感染组住院时间和糖尿病病史比例显著高于CHF未并发感染组,差异有统计学意义(P<0.05);CHF并发肺部感染组IgM、IgG、CD8+和CD4+/CD8+均低于CHF未并发肺部感染组,差异均有统计学意义(P<0.05);IgM、IgG、CD4+、CD8+和CD4+/CD8+在3组间比较,差异均有统计学意义(P<0.05);多元回归分析显示,IgG、CD4+/CD8+、住院时间是CHF并发肺部感染的独立危险因素,OR值分别为1.134、1.162和1.126。结论细胞免疫和体液免疫功能低下是CHF并发肺部感染的独立危险因素。 OBJECTIVE To explore the relationship between the immune function and the chronic heart failure (CHF) complicated by pulmonary infections so as to provide basis for the clinical treatment. METHODS The CHF patients were included in the study, and according to the status of pulmonary infections during the hospitalization, the patients were divided into the group of the CHF patients with pulmonary infections (the observation group) and the group of the CHF patients without pulmonary infections (the infection group). The difference in the peripheral blood T lymphocyte subsets(CD4 + , CD8 + and CD4 +/ CD8 +)and immunoglobulin(IgA, IgM and IgG) between the two groups were compared by the multivariate regression analysis, and the influence of the immune in- dicators on the incidence of pulmonary infections was observed. RESULTS The proportion taken by the patients with hospital stay and diabetes was significantly higher in the observation group than in the control group, the difference was statistically significant (P〈0.05). The concentration of IgM, IgG, CD8 + and CD4 + / CD8 + were significantly lower in the observation group than that of the control group. The differences in the IgM, IgG, CD4 + , CD8 + ,and CD4 +/CD8 + between the three groups were statistically significant. Multivariate regression a- nalysis found that the IgG, CD4 +/CD8 + , and the hospital stay were the independent risk factors for the CHF com- plicated by the pulmonary infection, the OR values were 1. 134, 1. 162, and 1. 126, respectively. CONCLUSION The decreased immune function was the risk factors of pulmonary infection in CHF patients.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2013年第2期305-307,共3页 Chinese Journal of Nosocomiology
关键词 免疫功能 心力衰竭 肺部感染 危险因素 Immune function Chronic heart failure Pulmonary infection Risk factors
  • 相关文献

参考文献6

二级参考文献35

  • 1李艳芳,杨清,郭永和,王建龙,成万均,王艳苹.不同心功能患者T淋巴细胞亚群的变化[J].中华老年心脑血管病杂志,2006,8(2):76-78. 被引量:13
  • 2何金生,李瑞珠,宗庭益.MTT还原法检测NK细胞活性的方法学研究[J].中国免疫学杂志,1996,12(6):356-358. 被引量:124
  • 3易文华,张永成,张柔玲.医院感染经济损失病例对照研究[J].中华医院感染学杂志,2006,16(10):1140-1142. 被引量:67
  • 4王辉.老年患者医院感染相关因素调查分析[J].中华医院感染学杂志,2007,17(7):800-800. 被引量:19
  • 5Fedak PW,Verma S,Weisel RD,et al.Cardiac remodeling and failure:from molecules to man(Part Ⅰ).Cardiovasc Pathol,2005,14:1-11.
  • 6Luzza F,Bmni F,Rizzo F,et al.Pathophysiology of congestive heart failure.Minerva Cardioangio1,2002,50:209-219.
  • 7Niethammer M,Sieber M,Von Haehling S,et al.Inflammatory pathways in patients with heart failure and preserved ejection fraction.Int J Cardiol,2008,129:111-117.
  • 8Zafrir N,Shohat B,Ben-Gal T,et al.Variations in lymphocyte activation during exercise testing in patients with coronary artery disease.Coron Artery Dis,2004,15:195-198.
  • 9Vredevoe DL,Widawski M,Fonarow CC,et al.Interleukin-6(IL-6)expression and natural killer(NK)cell dysfunction and anergy in heart failure.Am J Cardio1,2004,93:1007-1011.
  • 10Hansen PR,Rieneck K,Bendtzen K.Spironolactone inhibits production of proinflammatory cytokines by human mononuclear cells.Immunol Lett,2004,91:87-91.

共引文献1841

同被引文献96

  • 1杨建峰,魏经汉.慢性心力衰竭患者血清IL-1β、TNF-α水平及临床意义[J].实用全科医学,2007,5(11):954-955. 被引量:14
  • 2无.慢性心力衰竭诊断治疗指南[J].中华心血管病杂志,2007,35(12):1076-1095. 被引量:3756
  • 3Ogeng′o JA,Gatonga PM,Olabu BO,et al.Pattern of congestive heart failure in a Kenyan paediatric population[J].Cardiovasc J Afr,2013,24(4):117-120.
  • 4Forfia PR,Vaidya A,Wiegers SE.Pulmonary heart disease:the heart-lung interaction and its impact on patient phenotypes[J].Pulm Circ,2013,3(1):5-19.
  • 5Butrous G.The role of phosphodiesterase inhibitors in the management of pulmonary vascular diseases[J].Glob Cardiol Sci Pract,2014(3):257-290.
  • 6Sikkel MB,Hayward C,MacLeod KT,et al.SERCA2agene therapy in heart failure:an anti-arrhythmic positive inotrope[J].Br J Pharmacol,2014,171(1):38-54.
  • 7Azab B,Jaglall N,Atallah JP,et al.Neutrophil-lymphocyte ratio as a predictor of adverse outcomes of acute pancreatitis[J].Pancreatology,2011,11(4):445-452.
  • 8Zhang XM,Wang WJ,Yu YL,et al.BNP and NT-pro BNP assays for heart-failure diagnosis in patients with cerebral infarction[J].Laboratory Medicine,2013,44(1):46-50.
  • 9Mc Murray JJ,Adamopoulos S,Anker SD,et al.ESC gvjulelines for the diagnosis and treatment of acute and chronic heart failure 2012:the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology.Developed in collaboration with ihe Heart Failure Association(HFA)of the ESC[J].Eur J Heart Fail,2012,45(14):803-869.
  • 10Akpek M,Kaya MG,Lam YY,et al.Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention[J].Am J Cardiol,2012,110(5):621-627.

引证文献10

二级引证文献141

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部